Sionna Therapeuticsis shelving its highly anticipated cystic fibrosis drug candidate, SION-719, after it failed to meet the key endpoint in a proof-of-concept trial. Copyright ©2026Dow Jones & C⦠[+65 chars]
No comments yet. Be the first to comment!